144 related articles for article (PubMed ID: 8119939)
1. An in-frame deletion of codon 298 of the NADH-cytochrome b5 reductase gene results in hereditary methemoglobinemia type II (generalized type). A functional implication for the role of the COOH-terminal region of the enzyme.
Shirabe K; Fujimoto Y; Yubisui T; Takeshita M
J Biol Chem; 1994 Feb; 269(8):5952-7. PubMed ID: 8119939
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type).
Shirabe K; Yubisui T; Borgese N; Tang CY; Hultquist DE; Takeshita M
J Biol Chem; 1992 Oct; 267(28):20416-21. PubMed ID: 1400360
[TBL] [Abstract][Full Text] [Related]
3. Analysis of mutant NADH-cytochrome b5 reductase: apparent "type III" methemoglobinemia can be explained as type I with an unstable reductase.
Nagai T; Shirabe K; Yubisui T; Takeshita M
Blood; 1993 Feb; 81(3):808-14. PubMed ID: 8427971
[TBL] [Abstract][Full Text] [Related]
4. Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia.
Manabe J; Arya R; Sumimoto H; Yubisui T; Bellingham AJ; Layton DM; Fukumaki Y
Blood; 1996 Oct; 88(8):3208-15. PubMed ID: 8874222
[TBL] [Abstract][Full Text] [Related]
5. Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II.
Vieira LM; Kaplan JC; Kahn A; Leroux A
Blood; 1995 Apr; 85(8):2254-62. PubMed ID: 7718898
[TBL] [Abstract][Full Text] [Related]
6. Serine-proline replacement at residue 127 of NADH-cytochrome b5 reductase causes hereditary methemoglobinemia, generalized type.
Kobayashi Y; Fukumaki Y; Yubisui T; Inoue J; Sakaki Y
Blood; 1990 Apr; 75(7):1408-13. PubMed ID: 2107882
[TBL] [Abstract][Full Text] [Related]
7. [Molecular analysis of the structure of the mutant NADH-cytochrome b5 reductase gene causing methemoglobinemia].
Kobayashi Y
Fukuoka Igaku Zasshi; 1990 Jan; 81(1):41-7. PubMed ID: 2323714
[TBL] [Abstract][Full Text] [Related]
8. Structural role of serine 127 in the NADH-binding site of human NADH-cytochrome b5 reductase.
Yubisui T; Shirabe K; Takeshita M; Kobayashi Y; Fukumaki Y; Sakaki Y; Takano T
J Biol Chem; 1991 Jan; 266(1):66-70. PubMed ID: 1898726
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of hereditary methaemoglobinaemia, types I and II: two novel mutations in the NADH-cytochrome b5 reductase gene.
Higasa K; Manabe JI; Yubisui T; Sumimoto H; Pung-Amritt P; Tanphaichitr VS; Fukumaki Y
Br J Haematol; 1998 Dec; 103(4):922-30. PubMed ID: 9886302
[TBL] [Abstract][Full Text] [Related]
10. A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia.
Shirabe K; Landi MT; Takeshita M; Uziel G; Fedrizzi E; Borgese N
Am J Hum Genet; 1995 Aug; 57(2):302-10. PubMed ID: 7668255
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia.
Wang Y; Wu YS; Zheng PZ; Yang WX; Fang GA; Tang YC; Xie F; Lan FH; Zhu ZY
Blood; 2000 May; 95(10):3250-5. PubMed ID: 10807796
[TBL] [Abstract][Full Text] [Related]
12. Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency.
Katsube T; Sakamoto N; Kobayashi Y; Seki R; Hirano M; Tanishima K; Tomoda A; Takazakura E; Yubisui T; Takeshita M
Am J Hum Genet; 1991 Apr; 48(4):799-808. PubMed ID: 1707593
[TBL] [Abstract][Full Text] [Related]
13. [Leu 72 Pro mutation in the NADH-cytochrome b5 reductase gene found in a Chinese hereditary methemoglobinemia patient].
Wu Y; Huang C; Zhu Z
Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):195-7. PubMed ID: 11243135
[TBL] [Abstract][Full Text] [Related]
14. Role of cysteine residues in human NADH-cytochrome b5 reductase studied by site-directed mutagenesis. Cys-273 and Cys-283 are located close to the NADH-binding site but are not catalytically essential.
Shirabe K; Yubisui T; Nishino T; Takeshita M
J Biol Chem; 1991 Apr; 266(12):7531-6. PubMed ID: 2019583
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome b5 reductase: the roles of the recessive congenital methemoglobinemia mutants P144L, L148P, and R159*.
Davis CA; Crowley LJ; Barber MJ
Arch Biochem Biophys; 2004 Nov; 431(2):233-44. PubMed ID: 15488472
[TBL] [Abstract][Full Text] [Related]
16. Heterologous expression of enzymopenic methemoglobinemia variants using a novel NADH:cytochrome c reductase fusion protein.
Davis CA; Barber MJ
Protein Expr Purif; 2003 Jul; 30(1):43-54. PubMed ID: 12821320
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of recessive congenital methaemoglobinaemia type II: novel mutation in the NADH-cytochrome b5 reductase gene leading to stop codon read-through.
Leroux A; Leturcq F; Deburgrave N; Szajnert MF
Eur J Haematol; 2005 May; 74(5):389-95. PubMed ID: 15813912
[TBL] [Abstract][Full Text] [Related]
18. A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis.
Aalfs CM; Salieb-Beugelaar GB; Wanders RJ; Mannens MM; Wijburg FA
Hum Mutat; 2000; 16(1):18-22. PubMed ID: 10874300
[TBL] [Abstract][Full Text] [Related]
19. Familial idiopathic methemoglobinemia revisited: original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase.
Percy MJ; Gillespie MJ; Savage G; Hughes AE; McMullin MF; Lappin TR
Blood; 2002 Nov; 100(10):3447-9. PubMed ID: 12393396
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation found in the 3' domain of NADH-cytochrome B5 reductase in an African-American family with type I congenital methemoglobinemia.
Jenkins MM; Prchal JT
Blood; 1996 Apr; 87(7):2993-9. PubMed ID: 8639921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
